Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Teva Pharmaceutical
Teva Pharmaceutical
Gilead, Teva and J&J's HIV antitrust case inches closer to trial as judge keeps most claims on the table
Fierce Pharma
Wed, 02/22/23 - 06:54 pm
Gilead Sciences
legal
HIV
antitrust
Teva Pharmaceutical
JNJ
Teva gains FDA approval for once-daily formulation of flagship drug Austedo
Fierce Pharma
Wed, 02/22/23 - 10:09 am
Teva Pharmaceutical
FDA
Austedo
tardive dyskinesia
Huntington's disease
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints
PharmaLive
Thu, 02/9/23 - 10:35 am
Teva Pharmaceutical
earnings
After AbbVie, Teva walks away from influential trade group PhRMA
Fierce Pharma
Mon, 02/6/23 - 10:32 am
Teva Pharmaceutical
PhRMA
AbbVie
lobbying
Following in Lilly's footsteps, Teva takes 2nd long-acting schizophrenia drug into phase 3
Fierce Pharma
Tue, 01/31/23 - 12:31 pm
Teva Pharmaceutical
clinical trials
schizophrenia
Eli Lilly
antipsychotics
Olanzapine
TV-44749
Teva's opioid settlement moves forward with participation from 48 states
Endpoints
Mon, 01/9/23 - 10:39 pm
Teva Pharmaceutical
opioids
legal
Court swats down Vanda's patent suit against Teva and Apotex, clearing the way for Hetlioz generics
Fierce Pharma
Wed, 12/14/22 - 07:37 pm
legal
Vanda Pharmaceuticals
Teva Pharmaceutical
Apotex
patents
Hetlioz
EpiPen litigation comes back to haunt Teva a decade after initial settlements
Fierce Pharma
Tue, 12/6/22 - 10:50 am
EpiPens
Teva Pharmaceutical
legal
Viatris
NUVIGIL
Teva-partnered MedinCell bags $42M loan for long-acting injectable R&D
Fierce Pharma
Wed, 11/30/22 - 10:35 am
MedinCell
Teva Pharmaceutical
injectables
R&D
Teva, AbbVie's Allergan lock in $6.6B deal to settle thousands of US opioid lawsuits
Fierce Pharma
Sat, 11/26/22 - 07:11 pm
Teva Pharmaceutical
AbbVie
Allergan
opioids
legal
opioid crisis
Oxford Biomedica's next CEO to start in March; Kåre Schultz ready to wrap up Teva tenure early
Endpoints
Wed, 11/23/22 - 07:36 am
Pharma CEOs
Frank Mathias
Oxford BioMedica
Kåre Schultz
Teva Pharmaceutical
Richard Francis
As CEO Schultz eyes retirement, Teva taps former Sandoz head Francis as its next leader
Fierce Pharma
Mon, 11/21/22 - 10:30 am
Pharma CEOs
Teva Pharmaceutical
Kåre Schultz
Richard Francis
Sandoz
Take 2: Teva refiles for approval of long-acting schizophrenia drug months after FDA rejection
Fierce Pharma
Tue, 11/8/22 - 11:06 am
Teva Pharmaceutical
schizophrenia
FDA
mdc-IRM
Teva reaches $523M agreement with New York in latest opioid-related settlement
Endpoints
Sun, 11/6/22 - 01:34 pm
Teva Pharmaceutical
New York
legal
opioids
opioid crisis
Teva takes $215M hit from currency effects, but CEO says business is stable otherwise
Fierce Pharma
Thu, 11/3/22 - 12:06 pm
Teva Pharmaceutical
earnings
opioids
If at first... pharma’s most drawn-out development timelines revealed
EP Vantage
Thu, 11/3/22 - 10:54 am
Kyowa Kirin
Takeda
Eiger BioPharmaceuticals
AstraZeneca
Teva Pharmaceutical
Bavarian Nordic
Halozyme
Novartis
MannKind
drug development
Teva reports data from Huntington’s disease-linked chorea trial
Clinical Trials Arena
Wed, 10/19/22 - 10:54 am
Teva Pharmaceutical
Austedo
clinical trials
chorea
Huntington's disease
Teva abused patent system and spread misinformation about a Copaxone rival, European officials say
Fierce Pharma
Mon, 10/10/22 - 06:51 pm
Teva Pharmaceutical
Europe
Copaxone
legal
pharma marketing
In 'skinny' label fight between Teva and GSK, Supreme Court asks Biden admin for help
Fierce Pharma
Tue, 10/4/22 - 11:01 am
GSK
Teva Pharmaceutical
Joe Biden
Supreme Court
skinny labels
Teva settles price-fixing claims with Georgia for a 'modest' $3.3M
Fierce Pharma
Fri, 09/30/22 - 12:33 pm
Teva Pharmaceutical
price fixing
Georgia
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »